We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TDSGF market cap is 6.71M. The company's latest EPS is CAD -0.0364 and P/E is -3.30.
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.31M | -1.26M | -2.11M | -2.82M | -2.72M |
Net Income | -1.24M | -1.07M | -2.11M | -2.82M | -2.71M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 1.17M | 3.84M | 2.83M | 2.93M | 965k |
Total Liabilities | 393k | 154k | 230k | 313k | 375k |
Total Equity | 775k | 3.69M | 2.6M | 2.61M | 590k |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -1.12M | -1.11M | -1.8M | -2.63M | -2.46M |
Investing | -8k | -9k | -25k | -69k | -5k |
Financing | 2.03M | 3.83M | 876k | 2.68M | 587k |
Market Cap | 6.71M |
Price to Earnings Ratio | -3.30 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.21 |
Price to Book Ratio | 15.16 |
Dividend Yield | - |
Shares Outstanding | 74.56M |
Average Volume (1 week) | 56.17k |
Average Volume (1 Month) | 17.33k |
52 Week Change | -38.25% |
52 Week High | 0.1917 |
52 Week Low | 0.069 |
Spread (Intraday) | 0.04 (37.75%) |
Company Name | Telo Genomics Corporation (QB) |
Address |
1200-750 west pender st vancouver, british columbia V6C 2T8 |
Website | https://www.telodx.com |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions